Embargo Policy

Embargo Policy

All information updates to National Comprehensive Cancer Network® (NCCN®) Content items including, but not limited to, the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), the NCCN Drugs & Biologics Compendium (NCCN Compendium®), NCCN Biomarkers Compendium™, and the NCCN Chemotherapy Order Templates (NCCN Templates®) are embargoed until published on the NCCN website, NCCN.org. Upon request, and in limited cases, NCCN permits the use of embargoed information by those licensees of NCCN Content who are contracted to integrate, reference, or render NCCN Content in order to ensure accuracy and timeliness of data represented in various Health Information Technology Tools (“Pre-Release”), provided they agree to the following terms and conditions:

  • NCCN strictly prohibits Content from being disseminated, distributed, or shared beyond the licensee’s internal integration and testing.
  • NCCN strictly prohibits embargoed NCCN Content in a health information technology tool from being made publicly available until receipt of written notification from NCCN indicating that the Content has been published. This notification may come in the form of a NCCN Flash Update™, which indicates the public release of the NCCN Content.
  • “Health Information Technology Tools” includes, but is not limited to, clinical decision support tools, pre-authorization tools, mobile applications, and electronic health record systems.
  • NCCN reserves the right to deny a licensee Pre-Released content for any cause.
  • Failure to meet the provisions of this policy will be considered a violation of the Confidentiality language within your contract.

All applicable licensees are provided with a copy of this embargo policy as part of, or in addition to, their contractual agreement.